NCT01001481已完成不适用
Clinical Audit and Feedback Program to Determine Risk for Medication Adherence in Outpatients Diagnosed With Schizophrenia in Australia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 550
- 主要终点
- Primary outcome measure is the Clinical Assessment of Adherence as rated by the Investigators
研究概览
简要总结
The primary objective of this treatment review and feedback program is to quantify the risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia.
详细描述
The primary objective of this treatment review and feedback program is to quantify the risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia. Observational study - no study drug administered
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV
- •Currently treated in an outpatient clinic
- •Able to provide informed consent
- •Concurrent enrolment in clinical trials is acceptable
- •Have completed all questions on the Drug Attitude Inventory (DAI-10) and Medication Adherence Rating Scale (MARS) survey
排除标准
- 未提供
结局指标
主要结局
Primary outcome measure is the Clinical Assessment of Adherence as rated by the Investigators
时间窗: 6 months, 12 months
次要结局
- Clinical exacerbations (worsening of symptoms)(6 mths, 12 mths)
- Medication changes(6 mths, 12 mths)
研究者
相似试验
进行中（未招募）
不适用
Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary CareKnee OsteoarthritisNCT06283147Chinese University of Hong Kong228
已完成
不适用
Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access ProgramLong-chain Fatty Acid Oxidation Disorders (LC-FAOD)NCT03768817Ultragenyx Pharmaceutical Inc20
Unknown
不适用
Feedback System of PROMS in Children With BurnsBurnsNCT02607852Stephanie Romo35
Unknown
不适用
NECROtizing Soft Tissue Infections and Their Scoring SystemNecrosisNCT05224817Methodist Health System1,010
已完成
不适用
Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson DiseaseWilson DiseaseNCT04531189Ultragenyx Pharmaceutical Inc16